Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
600196
Classifica tra le azioni
#2198
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. engages in the pharmaceutical... Shanghai Fosun Pharmaceutical (Group) Co., Ltd. engages in the pharmaceutical business in Mainland China and internationally. It operates through five segments: Pharmaceuticals, Medical Devices and Medical Diagnosis, Medical Services, Medical Distribution and Retail, and Others. The company is involved in the pharmaceutical manufacturing in the therapeutic areas of solid oncology, including tumors and hematologic malignancies, as well as immune-inflammatory disorders, metabolism and digestive systems, anti-infection, central nervous system, cardiovascular system, and APIs and intermediates. It also offers mRNA vaccines; medical aesthetic devices, such as medical aesthetic capital equipment, aesthetic dentistry, injectables, and personal care business units; mechanical ventilation devices under the Breas brand; and mobile pre-hospital care; professional in-hospital surgery and covers medical devices; and high-end surgical robots and medical consumables. In addition, the company provides diagnostics solutions comprising biochemical diagnostics, immune diagnostics, molecular diagnostics, microbiological diagnostics, pathological diagnostics, and chronic care management; and healthcare services, specialized medical treatment, online and offline medical services, and insurance services. Further, it engages in the operation of hospitals; and distribution and retail of healthcare products. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. was founded in 1994 and is based in Shanghai, China.
Prezzo delle azioni
$3.40
Capitalizzazione di mercato
$9.07B
Variazione (1 giorno)
-1.61%
Variazione (1 anno)
-16.08%
Paese
CN
Scambia Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (600196)
Categoria
Healthcare
Storico del rendimento da dividendi per Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (600196)
Il rendimento da dividendi (TTM) di Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (simbolo azionario: 600196) al 2026 è: 0
Rendimento medio negli ultimi 5 anni: 2.09%
Rendimento medio negli ultimi 5 anni: 2.09%
Storico del rendimento da dividendi per Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (600196) da 2001 a 2026
Rendimento da dividendi alla fine di ogni anno (TTM)
| Anno | Rendimento da dividendi | Cambia |
|---|---|---|
| 2025 | 1.20% | -61.41% |
| 2024 | 3.11% | -15.49% |
| 2023 | 3.68% | 135.90% |
| 2022 | 1.56% | 77.27% |
| 2021 | 0.88% | 22.22% |
| 2020 | 0.72% | -40.00% |
| 2019 | 1.20% | -63.30% |
| 2018 | 3.27% | 149.62% |
| 2017 | 1.31% | -41.26% |
| 2016 | 2.23% | 8.78% |
| 2015 | 2.05% | 3.02% |
| 2014 | 1.99% | 8.15% |
| 2013 | 1.84% | -24.90% |
| 2012 | 2.45% | -8.58% |
| 2011 | 2.68% | 127.12% |
| 2010 | 1.18% | 6.31% |
| 2009 | 1.11% | -43.65% |
| 2008 | 1.97% | 58.87% |
| 2007 | 1.24% | -82.18% |
| 2006 | 6.96% | 48.72% |
| 2005 | 4.68% | 38.05% |
| 2004 | 3.39% | 59.15% |
| 2003 | 2.13% | -2.29% |
| 2002 | 2.18% | 44.37% |
| 2001 | 1.51% | 0.00% |
Rendimenti da dividendi (TTM) di aziende simili o concorrenti
| Azienda | Rendimento da dividendi | Il paese |
|---|---|---|
| 0.00% |
DE
|
|
| 0.00% |
DE
|
|
| 0.00% |
JP
|
|
| 0.00% |
CH
|
|
| 0.91% |
IN
|
